Life Sciences

Framingham-based SCIEX said it has signed an exclusive co-marketing agreement with Pressure BioSciences Inc. of Easton.

Jean-Pierre Garnier has been appointed chairman of the board of Alzheon Inc., a Framingham-based private biopharmaceutical startup...

Worcester-based biopharmaceutical startup Nemucore Medical Innovations said it has closed its Series A financing round to fund...

Results published in the journal Scientific Reports suggest that Marlborough-based Ocata Therapeutics has developed technology that can...

The cost of prescription drugs is a hot-button issue and an important public policy matter to consider....

With its hybrid of open spaces and an educated workforce, Central Massachusetts is set to reap the rewards as the state's biomanufacturing initiative kicks into its second phase.

Marlborough-based Boston Scientific will expand its cancer treatment portfolio with the $70 million purchase of a portion of Texas-based CeloNova Biosciences.

Charles River Laboratories will re-open a Shrewsbury lab that has been shuttered since 2010 with a mixture...

RXi Pharmaceuticals of Marlborough said Thursday it has begun its first clinical trial of a compound to evaluate its ability to prevent retinal scarring.

The top executive for sales at Holliston life science researcher Harvard Bioscience has resigned during an overhaul of the company's sales team to focus on areas with higher growth potential, according to regulatory filings.